COH Cochlear Ltd
- 320.330
- -2.040-0.63%
Cochlear Ltd News
AU Evening Wrap: Australia Shares Rise 0.7%, Led by Real-Estate Stocks
Property trusts were the best performing sector, rising 1.8%.
Cochlear (ASX:COH) May Have Issues Allocating Its Capital
Institutions Along With Retail Investors Who Hold Considerable Shares InCochlear Limited (ASX:COH) Come Under Pressure; Lose 3.3% of Holdings Value
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
ACCC: Cochlear's Acquisition No Longer Includes Bone Conduction Solutions
ACCC: Cochlear's Acquisition No Longer Includes Bone Conduction Solutions
Australian Competition Regulator Approves Cochlear's Oticon Acquisition
Australian Competition Regulator Approves Cochlear's Oticon Acquisition
Investing in Cochlear (ASX:COH) Five Years Ago Would Have Delivered You a 104% Gain
Cochlear Stock Not Priced for Potential Vaccine Risks -- Market Talk
0241 GMT - Cochlear's share price doesn't seem to reflect risks, including from the potential launch of a vaccine against newborn hearing impairment, Morgan Stanley analyst Sean Laaman says. He thinks
AU Morning Wrap: Australia Shares Lift; Gold Reaches Record High
Stocks to watch: Washington H Soul Pattinson, Brickworks, Sigma Healthcare, Electro Optic Systems.
Cochlear Price Target Cut 7.2% to A$256.00/Share by Morgan Stanley
Cochlear Price Target Cut 7.2% to A$256.00/Share by Morgan Stanley
Cochlear Ltd's Dividend Analysis
Should You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?
Morgan Stanley Adjusts Cochlear's Price Target to AU$276 From AU$258, Keeps at Underweight
09:27 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts Cochlear's Price Target to AU$276 From AU$258, Keeps at Underweight Price (AUD): $336.10, Change: $+1.02, Percent Change: +0.31%
ASX Weekly Report for 19 Feb to 23 Feb 2024
In the coming week we have earnings reports from Coles and Woodside (Tues), Suncorp (Mon), Worley (Wed), Harvey Norman, Ramsay Health Care (Thur).
Cochlear's Valuation Implies Unrealistic Implant Growth -- Market Talk
0244 GMT - Cochlear's current valuation implies hearing-implant sales or operating leverage well in excess of company targets, Macquarie analysts write in a note. They tell clients that implant sale v
How These 4 ASX 200 Shares Just Gained Major Broker Upgrades
Four S&P/ASX 200 Index (ASX: XJO) shares have just gained some sizeable upgrades from leading brokers.
Cochlear's Buyback Pause Suggests Stock Is Expensive -- Market Talk
0225 GMT - Cochlear's decision to pause its share buyback suggests that management see the stock as expensive, Citi analyst Mathieu Chevrier writes in a note. He maintains a sell rating on the stock,
Cochlear Target Price Raised 15% to A$365.00/Share by Wilsons>COH.AU
Cochlear Target Price Raised 15% to A$365.00/Share by Wilsons>COH.AU
Australian Shares Flat as Mining, Financials Rally Offset Other Sectors' Losses
Australian shares were flat with a positive bias on Monday as losses in healthcare and information technology were offset by gains in miners, which rallied as base metal prices rose, and the heavily w
Cochlear's Decision to Pause Buyback Seems Unusual -- Market Talk
0358 GMT - Cochlear's decision to pause its share buyback is seen as an unusual signal by analysts at Jarden. They write in a note that the pause shows management preserving capital despite the Austra
Analysis
Price Target
No Data
